Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008; 29: 1270–5., , , , , , et al.
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med 2007; 58: 236–44., , , , , , et al.
Creatine deficiency syndromes. Mol Cell Biochem 2003; 244: 143–50..
Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 1996; 348: 789–90., , .
Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pediatr Res 1994; 36: 409–13., , , , , , et al.
Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 2000; 47: 511–3., , , , , , et al.
X-linked creatine deficiency syndrome: A novel mutation in creatine transporter gene SLC6A8. Ann Neurol 2002; 52: 227–31., , , , , et al.
Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 2001; 49: 518–21., , , , .
Absolute quantitation of water and metabolites in the human brain. II Metabolite concentrations. J Magn Reson B 1993; 102: 9–19., , .
Identification and quantitation of phenylalanine in the brain of patients with phenylketonuria by means of localized in vivo 1H magnetic-resonance spectroscopy. J Magn Reson B 1995; 107: 242–51., , , , .
The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study. J Inherit Metab Dis 2007; 30: 209–16., , , , , , et al.
Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 1999; 46: 925–8., , , , , , et al.
Encefalomiopatie mitocondriali in eta' pediatrica: incidenza dell'accumulo di acido lattico documentato con immagini di spettroscopia RM del protone. [in Italian.] Riv Neuroradiol 2001; 14: 149–52., , , , , , et al.
Incidence of cerebral lactic acidosis in children with mitochondrial encephalomyopathy. Int Soc Magn Res in Medicine (ISMRM); 2002; Honolulu, Hawai'I, USA; 2002: 984., , , , , , et al.
Succinate in dystrophic white matter: A proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol 2002; 52: 38–46., , , , , , et al.
Magnetic Resonance Spectroscopy and Imaging in Neurochemistry. New York: Plenum Press; 1997: 329–401., . Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In: , ed.
Ghezzi D, Goffrini P, Uziel G, Horvath R, Klopstock T, Lochmüller H, et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 2009; 41: 654–6.
Effects of riboflavin in children with complex II deficiency. Brain Dev 2006; 28: 576–81., , , , , , et al.
Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: Evidence of intramyelinic and vasogenic–interstitial edema. J Neuroimaging 2003; 13: 162–5., , , , .
MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003; 45: 393–9., , , , , .
Adult onset Niemann–Pick type C disease: A clinical, neuroimaging and molecular genetic study. Mov Disord 2003; 18: 1405–09., , , , , .
Magnetic resonance spectroscopy in Niemann–Pick disease type C: Correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 1994; 10: 228–32., , , , .
Schilder's encephalitis periaxialis diffusa. Arch Neurol Psychatry 1931; 25: 299..
Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988; 29: 463–71., , , , , .
Familial spongy degeneration of the central nervous system (Van Bogaert–Bertrand disease). An ultrastructural study. Acta Neuropathol (Berl) 1969; 12: 103–15., , .
In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy [Letter]. Lancet 1990; 336: 437–8., , , , .
Localized 1H NMR spectroscopy in Canavan's disease: A report of two cases. Magn Reson Med 1991; 19: 439–45., , , , .
Proton NMR spectroscopy of Canavan's disease. Neuropediatrics 1992; 23: 263–7., , , .
Water apparent diffusion coefficient and T2 changes in the acute stage of Maple Syrup Urine Disease: Evidence of intramyelinic and vasogenic-interstitial edema. J Neuroimaging 2003; 13: 162–5., , , , .
Quantitative proton MRS of Pelizaeus–Merzbacher disease: Evidence of dys- and hypomyelination. Neurology 2005; 65: 701–06., , , , , .
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology 2001; 56: 785–8., , , , , , et al.
Proton MR spectroscopic imaging in Pelizaeus–Merzbacher disease. Am J Neuroradiol 2003; 24: 1683–9., , , Nagae- , , , et al.
Magnetic resonance imaging in juvenile Canavan disease. Eur J Pediatr 1993; 152: 750–3., , , , , , et al.
A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla diseaseNeurology. 1999; 52(8):1668–72. [Published erratum appears in Neurology 1999; 53(5): 1162.], , , , , , et al.
Molecular pathogenesis of sialic acid storage diseases: Insight gained from four missense mutations and a putative polymorphism of human sialin. Biol Cell 2008; 100: 551–9., , , , , , et al.
Novel form of intermediate salla disease: Clinical and neuroimaging features. J Child Neurol 2005; 20: 814–6., , , .
Magnetic resonance imaging in neonatal nonketotic hyperglycinemia. Ped Neurol 2005; 33: 50–2., , , , .
Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia. Am J Neuroradiol 1993; 14: 629–35., , .
In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia. J Neuroimaging 2001; 11: 209–11., , , , , .
Mitochondrial respiratory-chain diseases. Review. N Engl J Med 2003; 348: 2656–68., .
Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Review. Biosci Rep 2007; 27: 69–85., , , , .
MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations. Am J Neuroradiol 2002; 23: 1095–100., , , , , .
Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics 2002; 33: 79–85., , , , , .
Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 1993; 35: 769–76., , , , , .
Proton MR spectroscopy of mitochondrial diseases: Analysis of brain metabolic abnormalities and their possible diagnostic relevance. Am J Neuroradiol 2003; 24: 1958–66., , , , , , et al.
Clinical diversity of pyruvate dehydrogenase deficiency. Ped Neurol 1994; 10: 276–83., , , , , , et al.
Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. Am J Neuroradiol 2003; 24: 33–41., , .
Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993; 43: 2484–90., , , , .
Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 1995; 45: 1193–8., , , , , .
Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Ped Neurol 1992; 8: 60–4., , , , .
Brain mitochondrial impairment in ethylmalonic encephalopathy. J Neurol 2004; 251: 755–6., , , , .
A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol 2003; 53: 252–8., , , , , , et al.
A rare disorder, ethylmalonic encephalopathy, is caused by mutations in a mitochondrial protein. Clin Genet 2004; 65: 460–2..
Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007; 39: 534–9., , , , , , et al.
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001; 124: 121–31., , , .
Muscle mitochondrial changes in cerebrotendinous xanthomatosis [Letter]. Ann Neurol 1991; 30: 734–5., , .
Mitochondrial enzyme deficiency in cerebrotendinous xanthomatosis. J Neurol Sci 1995; 129: 106–08., , .
Localized proton MR spectroscopy in infants with urea cycle defect. Am J Neuroradiol 2001; 22: 834–7., .
Proton MR spectroscopy in hyperhomocysteinemia with elevated blood methionine levels. J Magn Reson Imaging 2006; 23: 404–07., , , , , .
Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 2004; 174: 87–92., , , .
Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: Clinical and biochemical considerations. Review. Pediatr Res 1996; 40: 404–9., , , , , , et al.
Multi-slice proton MR spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: Report of two cases and review of the literature. Am J Neuroradiol 2001; 22: 831–3., , .
1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed 1991; 4: 192–200., , , .
MRI and MRS in HMG-CoA lyase deficiency. Ped Neurol 1999; 20: 375–80., , , , , .
MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. Am J Neuroradiol 1998; 19: 378–82., , .
3-Hydroxy-3-methylglutaryl-CoA lyase deficiency studied using 2-dimensional proton nuclear magnetic resonance spectroscopy. FEBS Lett 1986; 203: 49–53., , , .
L-2-Hydroxyglutaric aciduria: MRI in seven cases. Neuroradiology 1998; 40: 727–33., , , , .
L-2-Hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition? Review. Neurology 2004; 62: 1882–4., , , , , , et al.
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999; 213: 121–33., , , , .
Childhood white matter disorders: Quantitative MR imaging and spectroscopy. Radiology 2006; 241: 510–7., , , , , , et al.
GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 2006; 67: 273–9., , , , , , et al.
Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus–Merzbacher-like disease. Am J Hum Genet 2004; 75: 251–60., , , , , , et al.
2008 [Epub ahead of print]., , , , , , et al. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain
New syndrome characterized by hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Neuroradiol 2002; 23: 1466–74., , , , , , et al.
MR imaging and proton MR spectroscopy in adult Krabbe disease. Am J Neuroradiol 2000; 21: 1478–82., , , , , , et al.
Evidence of diffuse brain pathology and unspecific genetic characterization in a patient with an atypical form of adult-onset Krabbe disease. J Neurol 2000; 247: 226–8., , , , , , et al.
Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994; 36: 595–608., , , , , .
Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 2005; 64: 434–41., , , , , , et al.
Prominent brain axonal damage and functional reorganization in “pure” adrenomyeloneuropathy. Neurology 2007; 69: 1261–9., , , , , , et al.
Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002; 58: 901–07., , , , , , et al.
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27: 117–20., , , , , .
Infantile Alexander disease: Spectrum of GFAP mutations and genotype–phenotype correlation. Am J Hum Genet 2001; 69: 1134–40., , , , , , et al.
Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 1949; 72: 373–81, 3 pl..
Can MR imaging diagnose adult-onset Alexander disease? Am J Neuroradiol 2008; 29: 1190–6., , , , , , et al.
Alexander disease: Diagnosis with MR imaging. Am J Neuroradiol 2001; 22: 541–52., , , , , , et al.
Metabolic and destructive brain disorders in children: Findings with localized proton MR spectroscopy. Radiology 1991; 181: 173–81., , .
Infantile Alexander disease: A GFAP mutation in monozygotic twins and novel mutations in two other patients. Neuropediatrics 2002; 33: 194–8., , , , , , et al.
Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology 2003; 60: 819–25., , , , , .
Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann Neurol 1995; 37: 324–34., , , , , , et al.
Diffuse white matter disease in three children: An encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 1993; 24: 244–8., , , , , .
Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994; 35: 331–40., , , , , , et al.
Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology 1995; 45: 1526–32., , , , , , et al.
A new leukoencephalopathy with vanishing white matter. Neurology 1997; 48: 845–55., , , , , , et al.
The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27. Am J Hum Genet 1999; 65: 728–34., , , , , , et al.
Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002; 51: 264–70., , , , , , et al.
In vivo proton magnetic resonance spectroscopy of the brain in a patient with L-2-hydroxyglutaric acidemia. Pediatr Res 1994; 35: 614–6., , , .
Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: Neuropathological and biochemical study of two cases. Acta Neuropathol 1999; 97: 469–80., , , , , , et al.
Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol 2000; 100: 635–46., , , , , , et al.
Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am J Hum Genet 2001; 68: 831–8., , , , , , et al.
Megalencephalic leukoencephalopathy with subcortical cysts: An update and extended mutation analysis of MLC1. Hum Mutat 2006; 27: 505–12., , Mejaski- , , , , et al.
Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol 1996; 92: 206–12., , , .
Megalencephaly and leukodystrophy with mild clinical course: A report on 12 new cases. Brain Dev 1998; 20: 142–53., , , , .
Consciousness disturbances in megalencephalic leukoencephalopathy with subcortical cysts. Neuropediatrics 2003; 34(4): 211–4., , , , , , et al.
Severe metabolic abnormalities in the white matter of patients with vacuolating megalencephalic leukoencephalopathy with subcortical cysts. A proton MR spectroscopic imaging study. J Neurol 2001; 248: 403–09., , , , , , et al.
Magnetic resonance spectroscopy: A new guide for the therapy of adrenoleukodystrophy. Neurology 2005; 64: 406–07., .
Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease. Ann Neurol 2000; 48: 27–38., , , , , .
Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721–7., , .
Brain phenylalanine concentrations in phenylketonuria: Research and treatment of adults. Pediatrics 2003; 112: 1575–9., , , Nelson Jr M.